Improved Nucleoside (2′-Deoxy)Ribosyltransferases Maximize Enzyme Promiscuity while Maintaining Catalytic Efficiency
Open Access
- 17 October 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Chemical Biology
- Vol. 20 (11) , 2547-2553
Abstract
Nucleoside analogues have been extensively used to treat viral and bacterial infections and cancer for more than 60 years. However, their chemical synthesis is complex and often requires multiple steps and a dedicated synthetic route for every new nucleoside to be produced. Wild type nucleoside 2'-deoxyribosyltransferase enzymes are promising for biocatalysis. Guided by the structure of the enzyme from the thermophilic organism Chroococcidiopsis thermalis PCC 7203 (CtNDT) bound to the ribonucleoside analogue Immucillin-H, we designed mutants of CtNDT and the psychrotolerant Bacillus psychrosaccharolyticus (BpNDT) to improve catalytic efficiency with 3'-deoxynucleosides and ribonucleosides, while maintaining nucleobase promiscuity to generate over 100 distinct nucleoside products. Enhanced catalytic efficiency toward ribonucleosides and 3'-deoxyribonucleosides occurred via gains in turnover rate, rather than improved substrate binding. We determined the crystal structures of two engineered variants as well as kinetic parameters with different substrates, unveiling molecular details underlying their expanded substrate scope. Our rational approach generated robust enzymes and a roadmap for reaction conditions applicable to a wide variety of substrates.Keywords
All Related Versions
Funding Information
- NuCana
- Industrial Biotechnology Innovation Centre (IBioIC 2020-2-1)
- Wellcome Trust (217078/Z/19/Z)
- University of St Andrews
This publication has 24 references indexed in Scilit:
- Biotechnological synthesis of nucleoside analogs: Recent progress and perspectivesGreen Synthesis and Catalysis, 2026
- Transition State Analogs of Human DNPH1 Reveal Two Electrophile Migration MechanismsJournal of Medicinal Chemistry, 2025
- Immobilized Nucleoside 2′-Deoxyribosyltransferases from Extremophiles for Nucleoside BiocatalysisACS Omega, 2024
- Human 2′‐Deoxynucleoside 5′‐Phosphate N‐Hydrolase 1: The Catalytic Roles of Tyr24 and Asp80ChemBioChem, 2024
- Snapshots of the Reaction Coordinate of a Thermophilic 2′-Deoxyribonucleoside/ribonucleoside TransferaseACS Catalysis, 2024
- New trends in the biocatalytic production of nucleosidic active pharmaceutical ingredients using 2′-deoxyribosyltransferasesBiotechnology Advances, 2021
- Structure‐Guided Tuning of a Selectivity Switch towards Ribonucleosides in Trypanosoma brucei Purine Nucleoside 2′‐DeoxyribosyltransferaseChemBioChem, 2019
- The evolution of nucleoside analogue antivirals: A review for chemists and non-chemists. Part 1: Early structural modifications to the nucleoside scaffoldAntiviral Research, 2018
- 2′-Deoxyribosyltransferase from Leishmania mexicana, an efficient biocatalyst for one-pot, one-step synthesis of nucleosides from poorly soluble purine basesApplied Microbiology and Biotechnology, 2017
- New developments in nucleoside analogues biosynthesis: A reviewJournal of Molecular Catalysis B: Enzymatic, 2016